An adrenocortical carcinoma patient with multiple lung metastases - A case report

Shuen Fu Weng, Ching Chung Chang, Deng Huang Su, Yih Leong Chang

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)


Adrenocortical carcinoma is a rare cause of Cushing's syndrome. Its aggressive behavior leads to a poor prognosis. Mitotane (o,p′-DDD) is the mainstay of medical therapy, but the adverse effects often limit its use. We report on a patient with adrenocortical carcinoma who was treated with mitotane. A 42-year-old woman presented with Cushing's syndrome and hirsutism. There were lung metastases at diagnosis. Right radical adrenalectomy and multiple lung metastatectomy were performed. Six months later, mitotane was administered for widely-disseminated metastases. It was discontinued because of severe side effects including dizziness, headache, generalized weakness, nausea, and vomiting. The patient died of hepatic failure one year after diagnosis. In these patients, mitotane may be used immediately after surgical resection as an adjuvant therapy if residual tumors were considered. A low-dose mitotane regimen should be given with monitoring of the serum level of the drug to obtain an optimal effect. Systemic chemotherapy may be administered or combined with mitotane if the tumor is poorly responsive to mitotane or the patient can not tolerate the drug. More experience is needed to determine the effect of various treatments.

頁(從 - 到)105-109
期刊Tzu Chi Medical Journal
出版狀態已發佈 - 4月 2005

ASJC Scopus subject areas

  • 一般醫學


深入研究「An adrenocortical carcinoma patient with multiple lung metastases - A case report」主題。共同形成了獨特的指紋。